Back to Search Start Over

Refined estimates of local recurrence risks and the impact of the DCIS score adjusting for clinico-pathological features: Meta-analysis of E5194 and Ontario DCIS cohort studies

Authors :
Eileen Rakovitch
Lorie L. Hughes
William C. Wood
Wedad Hanna
Steven Shak
Sharon Nofech-Mozes
Robert Gray
Lawrence J. Solin
Sumei Gu
Lawrence Paszat
Rinku Sutradhar
Joseph A. Sparano
Sunil Badve
Michael Crager
Dave P. Miller
Frederick L. Baehner
Source :
Journal of Clinical Oncology. 35:528-528
Publication Year :
2017
Publisher :
American Society of Clinical Oncology (ASCO), 2017.

Abstract

528 Background: Better tools are needed to estimate the risk of local recurrence (LR; DCIS or invasive) after breast-conserving surgery (BCS) for DCIS to inform treatment decisions. The DCIS Score (DS) was validated as a predictor of LR in E5194 and Ontario DCIS Cohort (ODC) after BCS without radiation (Solin,2013; Rakovitch,2015). We performed a meta-analysis (MA) combining data from E5194 and ODC with additional follow-up from E5194 adjusting for pertinent clinico-pathologic factors to provide refined prediction estimates of LR risk after BCS alone. Methods: The MA used data from E5194 and ODC. Patients with positive margins and multifocality were excluded. Identical Cox regression models were fit including age at diagnosis ( < 50, ≥50 yr), tumor size (1cm, > 1cm), DCIS Score and year of surgery (before vs after 2000). Grade was not significant. MA was used to calculate precision-weighted estimates of 10 year LR risk by DS. Results: Combined cohort includes 773 pts (tamoxifen used in 20% E5194, 17% of ODC > 65 yr). The DS and the clinico-pathologic variables age, tumor size and year provided independent prognostic information on 10 yr LR risk (p≤.009). Hazard ratios from E5194 and ODC cohorts were similar for tumor size ≤1 vs. > 1cm (1.45, 1.47), age ≥50 vs. < 50 yr (0.61, 0.84) and surgery year after 2000 (0.67, 0.49). 10 yr LR risks by combinations of age, tumor size, and DS are detailed in Table. For patients ≥50 yr with tumors ≤1cm and low risk DS, the 10 yr LR risks range from 5.3-10.0%. A high risk DS is associated with a higher 10 yr predicted risk of LR in all subsets. 10 yr risk of contralateral BC was 5.4%. Conclusions: This MA provides refined estimates of 10 yr LR risk after BCS alone for DCIS. Adding clinico-pathologic factors to the DCIS Score provides enhanced prognostic LR risk estimates to guide individualized treatment decision-making. [Table: see text]

Details

ISSN :
15277755 and 0732183X
Volume :
35
Database :
OpenAIRE
Journal :
Journal of Clinical Oncology
Accession number :
edsair.doi...........8b893273fd5d823d0b056c7a2875c25c
Full Text :
https://doi.org/10.1200/jco.2017.35.15_suppl.528